Caitlin Burrows

Stock Analyst at Goldman Sachs

(2.00)
# 3,150
Out of 5,239 analysts
146
Total ratings
38.68%
Success rate
-7.88%
Average return

Stocks Rated by Caitlin Burrows

Lineage
Mar 20, 2026
Maintains: Buy
Price Target: $46$51
Current: $38.89
Upside: +31.14%
The Macerich Company
Mar 2, 2026
Maintains: Sell
Price Target: $15$17
Current: $22.24
Upside: -23.56%
Orthofix Medical
Feb 26, 2026
Maintains: Buy
Price Target: $24$20
Current: $12.18
Upside: +64.20%
SL Green Realty
Feb 9, 2026
Maintains: Sell
Price Target: $42$37
Current: $43.65
Upside: -15.23%
Hudson Pacific Properties
Jan 29, 2026
Maintains: Neutral
Price Target: $17$15
Current: $11.94
Upside: +21.44%
VICI Properties
Nov 28, 2025
Maintains: Buy
Price Target: $38$34
Current: $28.55
Upside: +19.09%
Terreno Realty
Oct 21, 2025
Maintains: Buy
Price Target: $64$71
Current: $65.91
Upside: +7.72%
First Industrial Realty Trust
Oct 21, 2025
Maintains: Neutral
Price Target: $53$59
Current: $62.39
Upside: -5.43%
Extra Space Storage
Aug 21, 2025
Downgrades: Neutral
Price Target: $169$146
Current: $144.79
Upside: +0.84%
Kilroy Realty
Aug 21, 2025
Downgrades: Sell
Price Target: $33
Current: $34.73
Upside: -4.98%
Maintains: Buy
Price Target: $28$25
Current: $15.23
Upside: +64.15%
Maintains: Buy
Price Target: $33$29
Current: $29.94
Upside: -3.14%
Upgrades: Buy
Price Target: $39$40
Current: $36.05
Upside: +10.96%
Maintains: Sell
Price Target: $27$30
Current: $31.23
Upside: -3.94%
Downgrades: Neutral
Price Target: $142$132
Current: $143.76
Upside: -8.18%
Maintains: Sell
Price Target: $15$16
Current: $20.02
Upside: -20.08%
Maintains: Neutral
Price Target: $20$23
Current: $23.55
Upside: -4.46%
Initiates: Buy
Price Target: $33
Current: $31.27
Upside: +5.53%
Maintains: Buy
Price Target: $307$340
Current: $311.28
Upside: +9.23%
Maintains: Buy
Price Target: $144$161
Current: $205.66
Upside: -21.72%
Initiates: Neutral
Price Target: n/a
Current: $47.70
Upside: -
Maintains: Buy
Price Target: $39$44
Current: $39.65
Upside: +10.97%
Maintains: Sell
Price Target: $120$112
Current: $59.01
Upside: +89.80%